全球間質幹細胞市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計間質幹細胞市場將從 2025 年的 41.3 億美元成長到 2034 年的 126.6 億美元，2026 年至 2034 年的複合年成長率為 13.24%。

受再生醫學和細胞療法研究進展的推動，全球間質幹細胞市場正經歷顯著成長。間質幹細胞因其在治療整形外科、自體免疫疾病和心血管疾病方面的潛力而受到廣泛研究。臨床試驗的增加和治療應用的拓展正在加速該領域的商業性發展。

關鍵成長要素包括慢性病發生率上升、老年人口增加、幹細胞研究經費投入增加。生物製藥公司正投資於可擴展的生產流程和冷凍保存技術，以提高產品的一致性和合規性。政府支持和不斷擴大的研究合作進一步增強了市場動態。

隨著幹細胞療法逐步走向商業化和監管核准，其未來前景依然光明。基因編輯、組織工程和個人化醫療領域的創新可望提升治療效果。隨著再生醫學意識的不斷增強，間質幹細胞市場有望實現持續的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球間質幹細胞市場：依產品與服務分類

• 市場分析、洞察與預測
• 產品（細胞、細胞株、試劑盒、培養基、試劑等）
• 服務

第5章：全球間質幹細胞市場：依工作流程類型分類

• 市場分析、洞察與預測
• 細胞獲取和分離
• 培養及冷凍保存
• 差異化
• 特徵評價

第6章：全球間質幹細胞市場：依類型分類

• 市場分析、洞察與預測
• 自體
• 同種

第7章 全球間質幹細胞市場：依分離來源分類

• 市場分析、洞察與預測
• 骨髓
• 臍帶血
• 周邊血
• 輸卵管
• 胎兒肝臟
• 肺
• 脂肪組織

第8章：全球間質幹細胞市場：依適應症分類

• 市場分析、洞察與預測
• 骨骼和軟骨修復
• 心血管疾病
• 發炎和免疫疾病
• 肝病
• 癌症
• GvHD
• 其他

第9章：全球間質幹細胞市場：依應用分類

• 市場分析、洞察與預測
• 疾病建模
• 藥物研發和藥物發現
• 幹細胞庫
• 組織工程
• 毒理學測試
• 其他

第10章：全球間質幹細胞市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Axol Bioscience Ltd
  • Stemcell Technologies
  • Merck KgaA
  • Lonza
  • Promocell GMBH
  • Cyagen
  • Celprogen Corporation
  • Cellcolabs
  • Stemedica Cell Technologies Inc
  • Cell Applications Inc

The Mesenchymal Stem Cells Market size is expected to reach USD 12.66 Billion in 2034 from USD 4.13 Billion (2025) growing at a CAGR of 13.24% during 2026-2034.

The Global Mesenchymal Stem Cells Market is witnessing significant growth driven by advancements in regenerative medicine and cell therapy research. Mesenchymal stem cells are widely studied for their potential in treating orthopedic disorders, autoimmune diseases, and cardiovascular conditions. Increasing clinical trials and expanding therapeutic applications are accelerating commercial interest in this field.

Major drivers include rising incidences of chronic diseases, growing geriatric populations, and increased funding for stem cell research. Biopharmaceutical companies are investing in scalable manufacturing processes and cryopreservation technologies to improve product consistency and regulatory compliance. Supportive government initiatives and expanding research collaborations further strengthen market dynamics.

Future prospects remain promising as stem cell therapies move toward commercialization and regulatory approvals. Innovations in gene editing, tissue engineering, and personalized medicine are expected to enhance treatment outcomes. As awareness about regenerative therapies grows, the mesenchymal stem cells market is poised for sustained long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products & Services

• Products (Cells & Cell Lines, Kits, Media, & Reagents, Others)
• Services

By Workflow Type

• Cell Sourcing & Isolation
• Culture & Cryopreservation
• Differentiation
• Characterization

By Type

• Autologous
• Allogenic

By Source of Isolation

• Bone Marrow
• Cord Blood
• Peripheral Blood
• Fallopian Tube
• Fetal Liver
• Lung
• Adipose Tissues

By Indication

• Bone and Cartilage Repair
• Cardiovascular Diseases
• Inflammatory and Immunological Diseases
• Liver Diseases
• Cancer
• GvHD
• Others

By Application

• Disease Modeling
• Drug Development & Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Axol Bioscience Ltd, Stemcell Technologies, Merck KgaA, Lonza, Promocell GMBH, Cyagen, Celprogen Corporation, Cellcolabs, Stemedica Cell Technologies Inc, Cell Applications Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY PRODUCTS & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Products & Services
• 4.2. Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY WORKFLOW TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Workflow Type
• 5.2. Cell Sourcing & Isolation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Culture & Cryopreservation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Differentiation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Characterization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Autologous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Allogenic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY SOURCE OF ISOLATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Source Of Isolation
• 7.2. Bone Marrow Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Cord Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Peripheral Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Fallopian Tube Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Fetal Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Lung Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Adipose Tissues Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY INDICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Indication
• 8.2. Bone and Cartilage Repair Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Inflammatory and Immunological Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Liver Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. GvHD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Application
• 9.2. Disease Modeling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Drug Development & Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Stem Cell Banking Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Tissue Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Toxicology Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Products & Services
  • 10.2.2 By Workflow Type
  • 10.2.3 By Type
  • 10.2.4 By Source Of Isolation
  • 10.2.5 By Indication
  • 10.2.6 By Application
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Products & Services
  • 10.3.2 By Workflow Type
  • 10.3.3 By Type
  • 10.3.4 By Source Of Isolation
  • 10.3.5 By Indication
  • 10.3.6 By Application
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Products & Services
  • 10.4.2 By Workflow Type
  • 10.4.3 By Type
  • 10.4.4 By Source Of Isolation
  • 10.4.5 By Indication
  • 10.4.6 By Application
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Products & Services
  • 10.5.2 By Workflow Type
  • 10.5.3 By Type
  • 10.5.4 By Source Of Isolation
  • 10.5.5 By Indication
  • 10.5.6 By Application
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Products & Services
  • 10.6.2 By Workflow Type
  • 10.6.3 By Type
  • 10.6.4 By Source Of Isolation
  • 10.6.5 By Indication
  • 10.6.6 By Application
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL MESENCHYMAL STEM CELLS INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Thermo Fisher Scientific Inc
  • 12.2.2 Axol Bioscience Ltd
  • 12.2.3 Stemcell Technologies
  • 12.2.4 Merck KgaA
  • 12.2.5 Lonza
  • 12.2.6 Promocell GMBH
  • 12.2.7 Cyagen
  • 12.2.8 Celprogen Corporation
  • 12.2.9 Cellcolabs
  • 12.2.10 Stemedica Cell Technologies Inc
  • 12.2.11 Cell Applications Inc